DR. ONYIII
Transcript of DR. ONYIII
INTRODUCTION
Aging is an inevitable part of life that brings
along some inconvenient events, such as physiological
decline and disease. Abrass, (1990) hypertension is a
risk factor in cardiovascular disease morbidity and
mortality, particular in the elderly. It is a
significant and often asymptomatic chronic disease,
which requires optimal control and persistent adherence
to prescribed medication to reduce the risk of
cardiovascular, cerebrovascular and renal disease,
(Hamphton, 2003). Hypertension in the elderly patient
represents a management dilemma to cardiovascular (CV)
specialists and other practioners.
Further more, with the wide adoption of multiple
drugs strategies targeting subgroups of hypertensive
patients with specific risk conditions to how blood
pressure (BP) beyond traditional goals, difficult
questions arises about how aggressive elderly patients
should be treated “is hypertension in the elderly an
emergency state or not?” Does the blood Pressure
control lower the risk associated with cardiovascular
disease and death in the geriatric population?” “What
1
are the general principles of hypertension management
in this population?” the purpose of the following
article is to answer those questions through a review
of pathophysiology of aging, clinical assessment and
diagnosis of hypertension and finally recommendations
for its management.
Definition
Hypertension is defined by the seventh report of
the joint National committee on prevention, detection,
Evaluation and treatment of high blood pressure (JNC-
7., 2003) as a systolic blood pressure greater than
140mmHg and a diastolic pressure greater than 90mmHg
based on the average of two or more accurate blood
pressure measurement taken during two or more contact
with health care provider, (Suzanne et al 2010).
OBJECTIVES
This seminar work is discussed under the following
objectives
1. Explain the pathophysiology of Hypertension
2. Outline the causes and prevention of Hypertension
2
3. Discuss the complication associated with
hypertension
EPIDEMIOLOGY
As our population ages, the important of
cardiovascular disease (CVD) as the leading cause of
death in adult became increasing clear. (Health U.S,
2007). One major reason for this trend is the pattern
of hypertension changes and increasing hypertension
prevalence with age (about 1billion people worldwide),
(Kearnely et al, 2005) according to JNC -7 hypertension
occurs in more than two thirds of individuals after age
of 65 years (Chobanian et al data, 2003). From the
Framingham heart study, in men and women after free of
hypertension at 55years of age indicate that, the
remain lifetime risks for development of hypertension
through 80years are 93% and 91% respectively, (Levy et al,
1996). In other words, more than 90% of individuals who
are free of hypertension at 55years of age will develop
it during their remaining life span.
From the standpoint of epidemiology and
pathophysiology, some subgroups with particular
3
characteristics such as elderly women and blacks that
require additional focus. Hypertension prevalence is
less in women than in men until 45years of age, is
similar in both sexes from 45 to 64 and is much higher
in women than in men over 65years of age, (Health U.S,
2007). The severity of hypertension increase markedly
with advancing age in women as well, after the age of
60years, the majority of women (age 60-79 years: 48.8%,
age≥80years:63%) has stage ii hypertension
≥160/100mmHg) or receives hypertensive therapy
(Wasserthel et al, 2000).
Furthermore, blood Pressure control is difficult to
achieve in elderly women, (Pimenta, 2012). Endothelial
dysfunction, increased arterial stiffness, obesity,
genetic factors, elevated total cholesterol and low
high-density lipoprotein cholesterol levels have been
implicated in menopause- related blood pressure
elevation rather than ovarian failure per se, (Cifkova,
2008).
Hypertension among blacks is earlier in onset,
more severe and uncontrolled and contributes to the
highest coronary artery disease (CAD) mortality rates
4
in the USA in addition to the highest morbidity and
mortality attributed to stroke, left ventricular
hypertrophy (LVH), heart failure (HF) and chronic
kidney disease (CKD), (Chobanian et al, 2003). Compared
with whites, black are more likely to have
hypertension, more likely to be aware of it and more
likely to pharmacologically treated, but less likely to
achieve blood pressure control, (Hertz et al, 2003).
Hypertension is an important factor in the
disproportionate decrease life expectancy for black.
African-American men of 70.00 years versus of 75.90
years for white men and African-American women of 76.80
years versus of 80.80 years for women, (Heron et al,
(2009).
BLOOD PRESSURE REGULATION
Blood pressure is regulated through several
physiological mechanisms to ensure an adequate tissue
blood pressure. Blood pressure is determined by the
rate of flow of blood produced by the heart (cardiac
output) and the resistance of the vessels to blood
flow.
5
The resistance produced mainly in the arterioles
and is known as the systematic vesicular resistance.
There are several physiological mechanisms that allow
blood pressure to maintain into normal range such as:
- The autonomic nervous system-is most rapidly
responding regulator of blood pressure and receive
continues information from the baroreceptors situated
in the carotid sinus and the aortic arch. This
information is relay to the vasomotor Centre. A
decrease in blood pressure causes activation of the
sympathetic nervous system resulting in increased
contractility of the heart (β-receptors) and
vasoconstriction of both arterial and venous side of
the circulation α-receptions, (Abrass, 1990)
- The capillary fluid shift mechanical-this also
refers to the exchange of fluid that occurs across the
capillary membranes between the blood and the
interstitial fluid. The fluid movement is controlled by
the capillary blood pressure, the interstitial fluid
pressure as well as colloid osmotic pressure of the
plasma. Low blood pressure results in the fluid moving
from the intestinal space into circulation helping to
6
restore blood volume and blood pressure, (Levy et al,
1996).
- Hormonal mechanism exist both for lowing and
raising blood pressure, they act in various ways
including vasoconstriction and vasodilatation. The
principal hormones raising blood pressure are
a. adrenaline and nor adrenaline: they increase cardiac
output and cause vasoconstriction;
b. Rennin angiotensin aldosterone production is increase in
the kidney when stimulated by hypotension.
Angiotensin 1 is converted in the lung to Angiotensin
II, which is a potent vasoconstrictor, (Chobanian,
2003).
- The kidneys help to regulate the blood pressure by
increasing the blood volume and by the rennin-
angiotensin system (RAS) described above. They are the
most important organs for the long-term control of the
blood pressure, (Chobaniun, 2003).
PATHOPHYSIOLOGY OF HYPERTENSION.
Blood pressure is the product of cardiac output and
peripheral resistance (BP=CO×PR). Cardiac output is the
7
product of heart rate and stroke volume. (CO=HR×SV). In
normal circulation, pressure is transferred from the
heart muscle to the blood each time the heart contracts
and then pressure is extended by the blood as it flows
through the blood vessels.
Hypertension can result from an increase in cardiac
output, an increase in peripheral resistance
(constriction of the blood vessels), or both. In
elderly, it can be as a result of elastic arteries
showing major physical changes with age. As they dilate
and stiffen, aorta and the proximal elastic arterials
dilate by approximately 10% with each beat of heart in
youth, while the muscular arteries dilate by only 3%
with each beat. Such difference in degree of stretch
can explain difference in aging between proximal and
distal arteries on the basis of fatigue, (O’ rourke et
al, 2007). The result is a stiff artery that has
decreased capacitance and limited recoil and is thus
unable to accommodate the changes that occur during the
cardiac cycle.
Further more, during systole the
arteriosclerotic arterial vessel exhibit limited
8
expansion and fails to buffer effectively the pressure
generated by the heart causing an increase in systolic
blood pressure (SBP). On the other hand, the loss of
recoil during diastole results in reduction in
diastolic pressure (OBP) (Millar et al, 2000).
Neurohormonal and autonomic dysregulation:
Neurohormonal mechanisms such as the renin–angiotensin
aldosterone system decline with age. Plasma renin
activity at age of 60years is 40% to 60% of the levels
found in younger individuals, (Epstein, 1996). This has
been attributed to the effect of age-associated
nephrosclerosis on the juxtaglomerular apparatus.
Plasma aldosterone levels also decrease with age.
Consequently, elderly patients with hypertension are
more prone to drug-induced hyperkalaemia, (Flag, 1986).
In contrast, net basal sympathetic nervous system
activity increase with advancing age. Peripheral plasma
norepinephrine concentration in the elderly is double
the level found in the younger subject, (Seals et al,
2000). The age-associated rise in plasma norepinephrine
is thought to be a compensatory mechanism for reduction
in 𝜷-adrenergic responsiveness with aging.
9
Decreased baroreflex sensitivity with the age
causes orthostatic hypotension in the elderly, (Davis
et al, 1987) and (Kario et al, 1998)
CLASSIFICATION OF HYPERTENSION
Classifications of blood pressure for adult according
to JNC-7. Is in the table1 below
CLASSIFICATION SBP(mmHg) DBP(mmHg)Normal ≤120 And ≤80Pre-hypertension 120-139 Or 80-89Stage I
hypertension
140-159 Or 90-99
Stage 2
hypertension
≥160 Or ≥100
SBP: systolic blood pressure
DBP: diastolic blood pressure
OR
Guidelines from the European society of
hypertension/European society of cardiology (ESH/ESC
2007 and 2009 update) stratify hypertension somewhat
differently. Table II.
CLASSIFICATION SBP(mmHg) DBP(mmHg)10
Optimal ≤ 120 and ≤80
Normal 120-129 80-84
High normal 130-139 85-89
Hypertension
Grade 1 (mild) 140-159 90-99
Grade 2 (moderate) 160-179 100-109
Grade 3 (severe) ≥180 ≥90
Isolated systolic
hypertension
≥140 ≤90
TYPES OF HYPERTENSION
Primary hypertension: the type of hypertension that
has no known cause (idiopathic).
secondary hypertension: this is due to known cause
or underlying disease such as –
a. Renal failure
b. Hyperaldosteronism
c. Cushing syndrome
11
d. Coarctation of the aorta
e. Renovascular stenosis
f. Endocrine disorder (thyroid, parathyroid
abnormalities)
g. Obstructive sleep apnea
h. Drugs (nonsteroidal antiflammatory drugs, alcohol,
estrogen etc).
i. Chronic kidney disease
j. Pheochromocytoma.
CAUSES OF HYPERTENSION
Increased sympathetic nervous system activity related
to dysfunction of the autonomic nervous system.
Increase renal reabsorption of sodium, chloride, and
water related to a genetic variation in the pathways
by which the kidneys handle sodium.
Increased activity of the renin -angiotensin-
aldosterone system, resulting in expansion of
extracellular fluid volume and increase system
vascular resistance.
12
Decreased vasodilatation of the arterioles related to
dysfunction of the vascular endothelium.
Resistance to insulin action, which may be a common
factor linking hypertension, types two diabetes
mellitus, hypertriglyceridemia, obesity, and glucose
intolerance, (Suzanne et al, 2010).
The predisposing factors
1.High sodium intake: - Sodium causes smooth vascular
muscle to constrict smaller blood vessels creating
more resistance to blood flow thereby elevating your
blood pressure. Also sodium causes the body to retain
water, with additional water, more pressure exerted
against the blood vessels causing your blood pressure
to rise. The daily-recommended salt intake is 5g.
Americans consumes 2-4 time that amount.
2.Genetic: If hypertension runs in the family, it is
advisable to see your doctor to monitor your blood
13
pressure. Because the individual is at high risk of
hypertension.
3.Physiological influences: Imbalance of circulating
vasoconstrictors (e.g. angiotensin) and vasodilators
(e.g. prostaglandins), have been implicated to cause
hypertension. Also, increased sympathetic nervous
system activity resulting in increased
vasoconstriction. (Mary C, 2006).
4.Psychosocial influences: Suppressed anger and
hypertension have correlation according to Karren and
associates (2002). Some psychoanalysts believe this
may be associated with childhood rearing that forbid
expression of anger feelings, (Mary C, 2006).
5.Medications: Herbal supplements and some allergy
medications can also elevate blood pressure for e.g.
Aleve, Motrin, Advil, nasal decongestants and sprays,
also birth control pills. These can be interfering
with your blood pressure medication.
6.Alcohol: Excessive drinking is another factor that
causes hypertension; studies have shown that when
14
heavy drinkers reduce their alcohol consumption their
blood pressure drops to a minimal level.
7.Smoking: - Tobacco nicotine causes narrowing of the
blood vessels, whereby putting more strain on the
heart making your pressure go up, also smoking
cause’s plague build up which causes an increase in
blood pressure.
8.Aging factor: this is one factor we have to control
over as your get older your blood pressure tends to
increased.
9.Race: Studies have shown that Black Americans are at
the high risk for hypertension then white Americans.
Those with the lowest risk are white females, the
highest risk black females.
CLINICAL MANIFESTATIONS
Physical examination may reveal no abnormalities
other than elevated blood pressure. Occasionally,
Retinal changes such as hemorrhage, exudates (fluid
accumulation), arteriolar narrowing, and cotton wool
spots (small infarctions) occurs.
15
In severe hypertension, papillodema (a swelling of
the optic disk) may be seen.
People with hypertension may be asymptomatic and
remain so for many years. However, other signs are
headache, vertigo, flushed face, spontaneous nose
blood and blurred vision.
Chronic and progressive hypertension may reveal signs
and symptoms associated with specific organ system
damage. For example
Dyspnea, chest pain, or cardiac hypertrophy may
indicate cardiovascular damage.
Confusion and parasthesia may suggest
cerebrovascular damage and
Elevated serum creatinine or blood urea nitrogen
may signal kidney damage (May C, 2006).
MANAGEMENT/ TREATMENT OF HYPERTENSION IN THE ELDERLY
PEOPLE.
There are two types of management of hypertension
namely:
16
Non-pharmacological management and
Pharmacological management
NON-PHARMACOLOGICAL MANAGEMENT
Non-pharmacological management of hypertension is
too often over looked in the elderly, because many
patients prefer just being given a prescription and
continuing their current lifestyle, this course of
action is not ideal, the best way to treat is through
change of lifestyle. The popular option opinion is that
thirty minutes of exercise three times a week is
enough. If a patient needs to lower his blood pressure,
that is probably with enough exercise. Aim for at least
thirty minutes, six days a weak. Walking is a great
exercise.
Diet modification: - studies have shown that a diet
high in sodium contributes to high blood pressure.
Limiting the sodium can help. This reduces systolic
blood pressure to 2-8 mmHg.
Weight reduction: - Reduction in weight reduces the
systolic blood pressure by 5-2mmHg per 10kg less.
17
Moderate alcohol consumption: - Moderate consumption
of alcohol reduce hypertension by 2-4mmHg of systolic
blood pressure.
Dietary Approaches to stop hypertension (DASH) diet
which reduces the systolic blood pressure by 8-
14mmHg should be the cornerstone of hypertension
treatment in combination or not with active
treatment.
Individual with hypertension is advised to avoid
smoking because of how it causes the narrowing of the
blood vessels.
Relaxation techniques, such as meditation, Yoga,
hypnosis and biofeedback reduce blood pressure in
some individual. These are especially useful for
individuals with higher initial pressures and as
adjunctive therapy to pharmacological treatment.
Supporting psychotherapy, during which the individual
is encourage expressing honest feelings, particularly
anger, and may also be helpful.
PHARMACOLOGICAL MANAGEMENT OF HYPERTENSION IN THE
ELDERLY PATIENTS.
18
When life style measures or modifications fail to
lower blood pressure, pharmacotherapy should be
initiated. The safety and efficacy of multiple
medication classes has been studied in elderly patients
over the last 30 years. Randomized controlled trials
have consistently demonstrated that anti hypertension
therapy in the elderly effective in preventing total
mortality, stroke and coronary events, (Chobanian et al,
2003). Another important consideration is that for most
trials, the goal and achieved blood pressure are higher
than that recommended by JNC-7, which is still showing
a significant benefit of treatment.
GENERAL PRINCIPALS OF PHARMACOLOGICAL MANAGEMENT
There is often a debate about which
antihypertensive drug class should be used first in
elderly patients with hypertension. Because of several
classes of antihypertensive drugs available are
effective in preventing cardiovascular disease. The
principals are:
19
the treatment decisions most be guided by the pressure
of compelling indications such as diabetes mellitus,
stroke or heart failure and by the tolerability of
individual drugs or drug combination.
The initial antihypertensive drug should start at the
lowest does and gradually increased depending on the
blood pressure response to the maximum tolerated dose,
(Chobanian et al, 2008).
It then antihypertensive response to the initial drugs
is inadequate after reaching full dose, a second drug
from another class should be added.
If the anti hypertensive response is inadequate after
reaching the full dose of two classes of drug, a third
from another class should be added, (Chobanian et al,
2003).
PHARMACOLOGICAL AGENTS
The JNC-7 trial recommends a thiazide diuretic as
initial drug therapy or in combination with other
class, (Chobanian et al, 2003); Angiotensin-converting
enzyme inhibitors (ACEIs) can also considered for
first-line or combination, especially if diabetes,
20
heart failure, post myocardial infarction or chronic
disease is present.
In hypertensive parents with diabetes mellitus,
angiotensin receptor blockers (ARB) is considered first
line treatment as an alternative to ACELs in patients
with hypertension and heart failure who cannot tolerate
ACELs. Other line of tolerate are direct rennin
inhibitors, Aldosterone receptors antagonists and
centrally acting agents.
The details about the drugs which including the
mode of action, the classes, the dosage, the
indication, the contradiction, the side effect, the
Route of administration and nursing responsibilities
are summarized below.
THIAZIDE DIURETICS
These are slow or long acting diuretics, which are
usually effective for 12-24hours. Hence, they are
taking once daily, since potassium is lost in urine,
potassium supplements e.g. slow-k is usually
prescribed. Examples of Thiazide diuretics include
chlorothiazide, chlorthalidone, hydrochlorothiazide,
21
indapamide, methyclothiazide and metolazone
(zaroxolyn). One example is discussed below.
Chlorothiazide
Trade name: saluric, Diuril.
Group: - It is slow but long-acting Diuretics.
Mode of action: - It prevents sodium ion and chloride
reabsorption at the distal convoluted tubule of the
kidney thereby increasing the urinary output of the
electrolytes including potassium and water.
Indications: congestive cardiac failure, hypertension,
cirrhosis of livers, Nephrotic syndrome.
Dosage: 500mg-1g once or twice daily.
Route of Administration: Orally.
Side effects: Hpokalaemia, hypotension, Hypovolaemia,
Dehydration, dry month, muscle cramps,
thrombocytopenia, hyponatraemia.
Contra-indications: Shock, burns, cholera,
gastroenteritis, severe vomiting and severe diarrhea,
22
dehydration, hypertension, hepatic failure, rend
failure, pregnancy, lactation.
Nursing Responsibility: Monitor the intake client for
the patient. Give the prescribed potassium supplement
to prevent hpokalaemia. Weigh the patient daily. Advise
on how or restrict salt (sodium) intake in the diet to
enable this drug (Chlorothiazide to be effective).
Benefits or advantages of thiazide compare to other
line of drug are:
They decrease stroke and cardiovascular mortality in
elderly patients with hypertension.
Because of their wide availability and low cost
Their effect on calcium reabsorption constitutes the
basis for their usefulness in preventing the formation
of calcium containing renal stones.
They have protective effects on rates of bone mineral
loss and prevention of hip fracture.
DISADVANTAGE
Their disadvantages includes metabolic side effects
like
23
electrolyte abnormalities
dyslipidemia
Insulin resistant and new onset of diabetes
mellitus.
Angiotensin Converting Enzyme Inhibitors (ACEIs)
ACEIs are those anti hypertensive drug that inhibit
the conversion of angiotensin 1to angiotensin II in
multiple tissues and thus lower total peripheral
vascular resistance reducing blood pressure without
reflex stimulation of heart rate and cardiac output.
Examples of (ACEIs) are Captopril (Capoten), enalporil
(vasotec), enalaprilat (Vasotec IV), fosinopril
(monopril), lisinopril (Prinivil, zestril), ramipril
(altace) and trandolapril (marik). One example is
discussed below:
CAPTOPRIL
Trade name: epsitron, capoten
Group: It is an Anti- hypertensive and vasodilator
drug.
24
Mode of action: (1). It inhibits the conversion of
angiotensin 1 to a vasoconstrictor called angiotensin
II in the kidney by inhibiting Angiotensin converting
enzyme called Rennin, thereby reducing the
vasoconstriction and peripheral resistance and
consequently. (2). It also reduces cardiac after-load
and increase cardiac output. (3). It promotes sodium
and water loss by reducing Aldosterone production,
which is responsible for sodium reabsorption from renal
tubules. This therefore increases urinary output of
sodium and water causing low blood volume in
circulation with a reduction in blood pressure.
Indication: Hypertension, congestive cardiac failure,
renal artery stenosis.
Dosage: the initially 12.5mg twice daily, then
increased to maintenance dose of 25mg twice daily which
should not exceed 50mg twice daily as required.
Route of administration: Orally.
Side effect: Agranulocytosis, Thrombocytopenia,
pemphigus, proteinuria, orthostatic hypotension, skin
rash, loss of taste (Ageusia), Neutropania, Angioedema,
25
fever, Acute renal failure, Nephrotic syndrome,
leucopenia.
Contra-indications: Aortic sternosis, pregnancy,
Lactation, hypersensitivity.
Nursing responsibilities: - since potassium is not lost
in urine during excretion of sodium and water when
Captopril is used, care must be taken not to give the
patient potassium supplement so as not to cause
hyperkalaemia. Monitor white blood cell count to avert
blood disorders observe onset of dry cough when taking
epsitron and act immediately.
ADVANTAGE OF ACEIs
Reduction in mortality of patients with myocardial
infarction.
Reduction in mortality of patients with left
ventricular dysfunction.
Reducing diabetic renal disease in elderly patient.
It also reduces the risk of sarcopenia in elderly.
Angiotensin II Receptor Blockers (ARBs)
26
Blockage of angiotensin II receptors directly
causes vasodilatation, reduces secretion of vasopressin
and reduces production and secretion of aldosterone.
The combined effect reduces blood pressure. The
examples are Candesartan, eprosartan, irbesartan,
losartan, telmisartan and valsartan.
Candesartan (Atacand)
Group: It is anti- Hypertensive drug
Mode of action: It blocks the angiotensin II receptors
causing vasodilatation, reduces secretion of
vasopressin and reduces production and secretion of
aldosterone.
Indication: Hypertension, renal failure, congestive
cardiac failure.
Dosage: 16-32mg twice daily.
Routs of administration: Oral
Side effects: Hypotension, cough, Angioedema, acute
renal failure, hyperkalaemia, skin rashes
Contra-induction: hypovolumic, pregnancy, aortic
stenosis.
27
Nursing Responsibilities: (1) Observe the onset of dry
cough when take and act immediately. (2). Monitor for
hyperkalaemia.
ADVANTAGE OF (ARBS)
Reduces heart rate and cardiac output
inhibit rennin release
it generate Nitrogen oxide (No)
Reduce vasomotor tone.
CALCIUM CHANNEL BLOACKERS
This drug appears well tolerated by the elderly
Hypertensive patient. They are heterogeneous groups of
drugs with different effects on heart muscle, sinus
node function, atrioventricular-conduction, peripheral
arteries and coronary circulation. The examples of the
drugs are Amlodipine (Norvase), felodipine (plendil),
isradipine (Dynacire CR), nicardipine (cardene). Below
is the discussion of one example to represent others.
28
Amlodipine (Novas)
Group: it is a long acting antihypertensive,
vasodilator and Anti-Angina drug.
Mode of Action: it dilates and relaxes blood vessels
thereby allowing blood to flow freely from the heart
and consequently reducing the blood pressure.
Indications: Hypertension, Angina pectoris, coronary
thrombosis.
Dosage: 5-10mg daily during or after meal.
Route of administration: Orally.
Side effects: Mild side effects include Headache,
fatigue, Dizziness, Nausea, Swelling of legs, and
flashing.
Contra-indications: hypersensitivity to
Dihydropyridines.
Nursing Responsibilities: (1). Precautions must be
taken before giving it to pregnant and lactating
mothers, and those with impaired hepatic function. (2).
Where a daily dose is missed, do not take a double dose
the next day. Just take only the day’s dose. However,
29
try not to miss a daily dose to obtain the maximum
effect of Amlodipine (Norvase). (3). Monitor the vital
signs closely.
MONOTHERAPY VS COMBINATION THERAPY
Both the 2009-updated ESH/ESC and ACCF/AHA 2011.
Expert consensus document on hypertension in the
elderly recommend the combination of two drugs as
initial treatment whenever hypertensive patients have
high initial blood pressure or a classified as being at
high cardiovascular risk, (Aronow et al, 2011). Trial
evidence of outcome reduction has been obtained
particular for combination of diuretic with an ACE
inhibitors or an angiotensin receptor antagonist and in
recent trials for the ACE inhibitor/calcium antagonist,
combination (the angiotensin receptor
antagonist/calcium antagonist combination also appears
to be effective), (Aronow et al, 2011). Enhanced efficacy,
reduced adverse effects, improved complains as well as
potential organ protections are the key benefits of the
combination therapy.
MEDICATION COMPLIANCE
30
Medication compliance is very important in the
treatment of hypertension. Medication compliance can be
defined as the extent to which a patient takes
medication as prescribed. Compliance rates are often
reported as percentage of prescribed does of medication
taken over a period. Unfortunately, a large proportion
of the elderly patients discontinue or takers they
drugs inappropriately. These non-compliances result in
failing to reach guidance-recommended blood pressure
targets. Older age, low risk for cardiovascular events,
competing health problems, low socio-economic status,
complexity (e.g. multiple dosing) side effects and cost
of medication regimen predict non-compliance.
NURSING MANAGEMENT
NURSING ASSESSMENT
A. Respiratory,
In assessing for respiration, you have to check for
shortness of breath after activity, cough with or
without sputum, smoking history by asking the patient
or the patient’s relative, addition sounds as the
patient breath, any signs and symptoms of cyanosis.
31
B. Circulation
In assess for circulation you have to check for
increase blood pressure of the patient, history or
signs and symptoms of coronary heart disease, signs and
symptoms of tachycardia, signs and symptoms of
palpitation.
C. Activity and rest.
In assessing for activity and rest, you have to check
for weakness, fatigue, shortness of breath, heart
frequency increase and changes that occur in heart
rhythm.
D. Elimination
Assess for history of kidney disease by examining the
pattern of elimination of the patient.
E. Food/Fluids
Check patient’s pattern of feeding such as those
foods that contain high salt, high fat and cholesterol.
Check for sign’s of fluid and electrolyte imbalance
such as nausea, vomiting, weight changes and edema.
32
F. Neuro-Sensory
Check for signs and symptoms such as headache,
throbbing, sub-occipital headache weakness on one side
of the body, visual disturbances (diplopia, blurred
vision) and epistaxis.
G. Pain/Discomfort
Assess for intermittent pain in the limbs, sub-
occipital headache, severe abdominal pain and chest
pain.
H. Ego Integrity
Check fro signs and symptoms such as anxiety,
depression, euphoria, irritability, facial muscle
tension, respiratory haul and increased speech
patterns.
I. Security
Assess the patient’s gait and signs of parenthesis and
postural hypertension.
NURSING DIAGNOSIS
33
Risk for ineffective tissue perfusion
Imbalanced nutrition more than body requirement.
Ineffective health maintenance.
Non-compliance with therapeutic regimen
Knowledge deficit
Acute pain
Risk for decreased cardiac output
PLANNING AND GOALS
To help the patient to understand the disease
process and its treatment.
To encourage the patient to participate in a self-
care program.
To reduce the complication or eliminate it.
NURSING INTERVENTION
The objective, of nursing care for patients with
hypertension focuses on lowering and controlling the
blood pressure without adverse effect and low cost
effect. To achieve these goals, the nurses must adhere
to the following:-
Support the patient to adhere to his/her treatment
regimen
34
Educate the patient the need to comply to his/her
treatment regimen
Advise the patient on good lifestyles.
The nurse needs to emphasize the importance
controlling hypertension rather than curing it.
The nurse can encourage the patient to consult a
dietitian to help develop a dietary plan for
improving nutritional intake or for weight loss.
Advise the patient to limit alcohol intake.
The nurse should advise the patient to avoid tobacco
because anyone with high blood pressure is already
at high risk for heart disease and smoking worsens
the situation.
Advice the patient to belong to a group for weight
Control, smoking cessation, and stress reduction is
helpful to the patient.
Encourage the patient to engage on regular physical
activity
The nurse should ensure to use proper blood pressure
measurement techniques.
The nurse should provide assistance with social
support.
35
Involve family members in educating programs to
enables them support the patient effort to control
hypertension.
Educate the patient the importance of reporting side
effects of any medication to health care providers.
Educate the patient on self blood pressure
monitoring
PREVENTION
1. Nutrition:
Reduce high intake of sodium in diet
Reduce high intake of food that is containing fat.
Increase intake of fruits and vegetables
2. Weight reduction.
Maintain normal body weight (body mass index18.5−24.9km /m2 ¿, by regular cheek of the body weight.
3. Physical Activity
Engage in regular aerobic physical activity such as
brisk walking for at least 30 minutes 3-6days a week.
This will help in reducing the blood pressure by 4-
9mmHg. Avoid sedentary life, help in reducing blood
pressure.
36
4. Moderation Of Alcohol Consumption
Limit the consumption of alcohol to one bottle per week
and whisky one shout per week in most men and to no
more than one drink per day in women and lighten-weight
people.
5. Smoking
Prohibit Smoking to avoid the high risk of hypertension
that may occur by the use of tobacco.
6. Psychosocial
Every individual should be encouraged to express their
anger or should be encouraged to do so since
suppression of anger feeling leads to high risk of
hypertension.
7. Medication
Medication compliance is very necessary to avoid
relapse and complication of the illness. The
patient/client should report any side effect of
medication to his physician immediately.
8. Genetics Counseling
An individual that are from a family that have the
history of hypertension should be advise to go for
37
medical check up regular for early detection and
control of hypertension.
9. Relaxation Techniques
An individual once a while should try to attend
recreation centers, watching of program that makes you
happy to avoid thinking, or issues that will make you
feel unhappy or sad at a time, which will cause slight
rise in blood pressure.
COMPLICATION
If hypertension is not treated:
it can leads to left ventricular hypertrophy
it can leads to myocardial infarction
It can cause cerebrovascular accident (CVA),
stroke, or brain attack.
it can cause renal insufficiency and failure to the
patient
it causes renal hemorrhage
it leads to transient ischemia attack (TIA)
It causes cognitive impairment and dementia to the
patients.
CONCLUSION38
Hypertension is an important risk factor for
cardiovascular morbidity and mortality, especially in
the elderly. Multiple trials have shown that it is safe
to treat hypertension in the elderly; it will decrease
the rate of stroke, heart failure and myocardial
infarction. Hypertension treatment also reduces the
incidence of cognitive impairment and dementia in the
elderly. The adoption of a healthy lifestyle is one of
the cornerstones of hypertension management. Evidence
has shown that several classes of anti hypertension
drugs are effective in preventing cardiovascular
disease, but usually no single drug is adequate to
control hypertension in most elderly people. Guide
individualization of treatment by the presence of
concomitant cardiovascular risk. For all those
aforementioned reasons, physicians should treat
hypertension in their patients regardless of their age.
RECOMMENDATIONS
In view of the above discussion, I recommend the
following:
The public should be properly educated on the
importance of regular check of blood pressure. 39
The health personal especially the Nurses should
teach the public the importance of exercise, eat
foods that are of low salt and fat continent.
Expert medical personal such as the nurses,
doctors, nutritionist and dietician who are qualify
should equally be employed by government to the
rural communities to teach, diagnose and treat the
at risk group for hypertension especially the
elderly.
40
REFERENCES
Abrass, I.B., (1990). The biology and physiology of
aging west J. Med. 153: 641-644.
Aronow, W.S., Fleg, J.L., Pepine, L.J., Artinian, N.T.,
Bakris, G. Ferdinard, K.C., Ann, F.M., Frishman, W.H;
Jaigobine. (2011). Expert consensus document on
hypertension in the elderly a report of the American
college of cardiology foundation Task force on
clinical. Expert consensus documents developed in
collaborative with the American Academy of Neurology,
American Geriatric society, American society or
preventive cardiology, American society of
Hypertension. American society of Nephrology,
Association of Black cardiologist and European
society of Hypertension J. Am coli curdiol. 57:2037-
2114.
Chobanian, A.V., Bakris, G.L., Black, H.R. Cushman,
W.L., Green, L.A; Jones, D.W., Materson, B.J.,
Oparil, S.,Wright, S.T., (2003). The seventh report
of the joint National committee on prevention,
41
Detection, Evaluation, and treatment of High Blood
Pressure. 289:2560-2572.
Cifkova, R., Pitta, J., Lejskouva, M. Lanska V; Zecova,
S. (2008). Blood pressure around the menopause.
Coylewright, M., Reckelhoff, J.F., Onyang, P.,
(2008).Menopause and hypertension and age-old debate.
Davis, B.R., Langford, G.G., Blaufox, M.D., Curb, J.D.,
Polk, B.F., Shulman, N.B., (1987). The association of
postural changes in systematic blood pressure and
mortality in persons with hypertension. The
hypertension detection and follow-up program
experiences.
Epstein, M., (1996).Aging and the kidney. JAM Soc
Nephrol.
Flag, J.C. (1986). Alterations in cardiovascular
structure and function with advancing age.
Hamilton, G.A. (2003). Measuring adherence in a
hypertension clinical trial.
Health united states. (2007). With Chart book on trends
in the health of Americans.
42
Heron, M., Hoyert, D.L., Murphy, S.L., Xu, J.,
Kochanek, K.D. Tejada-vera, B. (2009). Deaths final
data for 2006. Nat. vital state Rep. 2009, 57.1-134.
Hertz, R.P., Unger, A.N., Cornell, J.A; Sauhders, E.
(2005). Racial disparities in hypertension
prevalence, awareness, and management, 165:2095-2104.
Kannel, W.B., Dawher, F.R., Sorlie, P., Wolf, P.A.,
(1976). Components of blood pressure and risk of
atherothrombotic brain infarction. The framing study.
Kario, K., Eguchi, K., Nakagawa, Y., Motal, K.,
Shinada, K. (1998). Relationship between extreme
dippers and orthostatic hypertension in elderly
hypertensive patients.
Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P.,
Whelton, P.K. (2005). Global burden of hypertension
analysis of worldwide data.
Levy, C., Larsan, M.G., Vasan, R.S., Kannel, W.B.,
Hokk. (1996). the progression from hypertension to
congestive heart failure.
Mary, C.T. Psychiatric Mental heart nursing (5th Ed.)
43
Millar, J.A & Lever, A.F. (2000). Implications of pulse
pressure as a predictor of cardiac risk in patients
with hypertension.
Nanda Label hypertension. (Thursday. 19, 2012).
Necl, L., Benowitz, M.D., Basic and clinical
pharmacology. (10th Ed).
O’Rourke, M.F., Hashimoto, J. (2007). Mechanical
factors in arterial aging, a clinical perspective.
Pimenta, E. (2012). Hypertension in women.
Seals, D.R. and Esler, M.D. (2000). Human aging and the
sympathoadrenal system.
Suzanne, C., Smeltzer, Breda, G., Bare, Janice, Hunkle,
Kerry, H., Cheever, Brunner and Suddarth’s, Textbook
of medical;-surgical Nursing. (12th Ed.).
Wasserthal-smoller, S., Anderson, G., Psaty, B.M.,
Black, H.R., Manson, J., Wong, N. Francis, J., Grinm,
R., Kotchen, T., Langer, R: (2000). Hypertension and
its treatment in postmenopausal health initiative
hypertension.
44